U.S. Markets close in 35 mins.

Pharma-Bio Serv, Inc. (PBSV)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.40-0.04 (-10.03%)
As of 2:20PM EDT. Market open.
Full screen
Previous Close0.44
Open0.40
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.40 - 0.40
52 Week Range0.37 - 0.99
Volume21,695
Avg. Volume1,595
Market Cap9.24M
Beta-0.02
PE Ratio (TTM)-6.78
EPS (TTM)-0.06
Earnings DateSep 15, 2017 - Sep 18, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.00
Trade prices are not sourced from all markets
  • Pharma-Bio Serv, Inc. :PBSV-US: Earnings Analysis: Q3, 2017 By the Numbers : September 15, 2017
    Capital Cube10 days ago

    Pharma-Bio Serv, Inc. :PBSV-US: Earnings Analysis: Q3, 2017 By the Numbers : September 15, 2017

    Categories: Yahoo FinanceGet free summary analysis Pharma-Bio Serv, Inc. reports financial results for the quarter ended July 31, 2017. We analyze the earnings along side the following peers of Pharma-Bio Serv, Inc. – Willdan Group, Inc., ExlService Holdings, Inc. and NV5 Global Inc (WLDN-US, EXLS-US and NVEE-US) that have also reported for this period. Highlights Summary numbers: ... Read more (Read more...)

  • ACCESSWIRE11 days ago

    Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2017

    DORADO, PUERTO RICO / ACCESSWIRE / September 14, 2017 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB: PBSV), a compliance, project management and technology transfer ...

  • Zacks Small Cap Research3 months ago

    PBSV: Margin, Expense Improvement Offset Revenue Decline

    By Brian Marckx, CFA OTC:PBSV Fiscal Q2 2017 Results  Pharma-Bio Serv, Inc (OTC:PBSV) reported financial results for their fiscal second quarter 2017, ending April 30th.  Results were very similar to that ...